By Andrew Taylor

President Donald Trump on Friday signed an $8.3 billion measure to help tackle the coronavirus outbreak that has killed more than a dozen people in the U.S. and infected more than 200.

The legislation provides federal public health agencies with money for vaccines, tests and potential treatments and helps state and local governments prepare and respond to the threat. The rapid spread of the virus has rocked financial markets, interrupted travel and threatens to affect everyday life in the United States.

Trump had planned to sign the bill during a visit to the Centers for Disease Control and Prevention in Atlanta. But he told reporters Friday that concerns were raised about “one person who was potentially infected” who worked at the CDC. Trump said the person has since tested negative for the new virus, and the CDC was added to his schedule on Friday.

The Senate passed the $8.3 billion measure Thursday to help tackle the outbreak in hopes of reassuring a fearful public and accelerating the government's response to the virus. Its rapid spread is threatening to upend everyday life in the U.S. and across the globe.

The money would pay for a multifaceted attack on a virus that is spreading more widely every day, sending financial markets spiraling again Thursday, disrupting travel and potentially threatening the U.S. economy's decade-long expansion.

Thursday's sweeping 96-1 vote sent the bill to the White House for the president's signature. Sen. Rand Paul, R-Ky., cast the sole “no” vote. The House passed the bill Wednesday by a 415-2 vote.

The plan would more than triple the $2.5 billion amount outlined by the White House 10 days ago. The Trump proposal was immediately discarded by members of Congress from both parties. Instead, the bipartisan leadership of the House and Senate Appropriations committees negotiated the increased figure and other provisions of the legislation in a burst of bipartisan cooperation that's common on the panel but increasingly rare elsewhere in Washington.

“In situations like this, I believe no expense should be spared to protect the American people, and in crafting this package none was,” said Appropriations Committee Chairman Richard Shelby (R-Ala.) “It's an aggressive plan, a vigorous plan that has received an overwhelming positive reaction.”

Trump was sure to sign the measure, which has almost universal support. It is intended to project confidence and calm as anxiety builds over the impact of the virus, which has claimed more than a dozen lives in the U.S.

“The American people are looking for leadership and want assurance that their government is up to the task of protecting their health and safety," said Sen. Patrick Leahy (D-Vt.).

The impact of the outbreak continues to mount. The British government is considering suspending Parliament for five months in hope of limiting the spread of the virus in the United Kingdom.

The legislation would provide federal public health agencies money for vaccines, tests and potential treatments, including $300 million to deliver such drugs to those who need it. More than $2 billion would go to help federal, state and local governments prepare for and respond to the coronavirus threat. An additional $1.3 billion would be used to help fight the virus overseas. There's also funding to subsidize $7 billion in small business loans.

Other dollars would be directed to help local officials prepare for the potential worsening of the outbreak and subsidize treatment by community health centers. Medicare rules would be loosened to enable remote "telehealth" consultations whereby sick people could to get treatment without visiting a doctor.

Sen. Maria Cantwell (D-Wash.), whose state is at the center of the crisis, praised the bill because it “will increase access for public lab testing, help pay for isolation and quarantine, help pay for sanitizing in public areas, better track the virus and those who might come into contact with it, help labs who are trying to identify hot spots, and limit exposure."

The legislation contains a hard-won compromise that aims to protect against potential price gouging by drug manufacturers for vaccines and other medicines developed with taxpayer funds. Health and Human Services Secretary Alex Azar would have the power to make sure commercial prices are reasonable. Azar is a former drug industry lobbyist.

Democrats said other steps may be needed if the outbreak continues to worsen.

"This may be a first step because we have issues that relate to unemployment insurance for people who are put out of work." Pelosi said as she signed the bill to send it to Trump.

“We have only about 27% of people in this country who have paid sick days. So if they have to go home what is going to happen to them and their families?” said Rep. Rosa DeLauro (D-Conn.).

DeLauro said Pence responded that he would raise the issue with the president.

The bill seeks to restore $136 million that the Department of Health and Human Services cut from other accounts such as heating subsidies for the poor to battle the virus.

The legislation comes as carping over the administration's response to the outbreak is quieting down. Lawmakers in both parties had faulted a shortage of tests for the virus and contrasting messages from Trump and his subordinates. In an interview with Sean Hannity of Fox News on Wednesday, Trump downplayed the lethality of the virus, saying the World Health Organization's updated estimate of a 3.4% death rate in coronavirus cases is “a false number."

“Now you're starting to see rapid deployment of tests, which makes me feel better, quite honestly," said Rep. Raul Ruiz (D-Calif.), a doctor. “I think their communications are a little better. As long as the president doesn't contradict the experts and the scientists who know what they're doing, things will get better."

Share:
More In Politics
All Hands Celebrates Black History Month
All Hands celebrates Black History Month by highlighting achievements in inclusivity and paying homage to those who have fought for equal rights. Rep. Maxine Waters (D-CA) joins Cheddar News to discuss voter suppression; Damali Peterman, CEO of Breakthrough ADR, elaborates on the biggest barriers for Black professionals; Andre Perry, senior fellow of Brookings Institution, dives into student loans and the racial wealth divide; and lastly, BET CEO Scott Mills discusses the company's initiatives for 2022.
Black History Being Made On Capitol Hill
All month long Cheddar News is celebrating Black History Month. In our nation’s capital, Black history is being made right now. cheddar's own Arielle Hixon puts the spotlight on three lawmakers making that happen, Rep. Lauren Underwood (D-IL), Rep. Cori Bush (D-MO), and Sen. Tim Scott (R-SC).
Rep. Maxine Waters on Voter Suppression, SCOTUS During Black History Month
Representative Maxine Waters (D-Calif. 43rd District) joined Cheddar News to talk about the current political climate in America, including efforts to roll back voting rights in multiple states in light of Black History Month. "Why do we have to deal with those who still believe that somehow this country only belongs to the whites of the country and that somehow they have to do everything that they can to undermine our voting and do voters suppression to keep us from being influential and at the table by which to solve problems?" she asked. Waters chided "two Democrats" who she said were stymying attempts to rectify the issue and also spoke on President Biden’s promise to nominate a Black woman to the Supreme Court.
Interest Rates Remain Unchanged Though Hikes Loom
Wall Street saw another volatile day after the Federal Reserve left rates unchanged for now, with plans to raise rates in March at its next meeting in order to ease inflation. Fed Chair Jerome Powell said the Fed has not made decisions on the size of rate increases, adding that the Fed is not trying to get inflation below two-percent. Ken Johnson, CFA and Investment Strategy Analyst explains why Powell thinks that high inflation is a significant threat to the labor market.
Factorial Energy Raises $200 Million to Accelerate Commercialization of Its Solid-State Batteries for Electric Vehicles
Solid-state battery maker Factorial Energy recently raised $200 million in a Series D round led by Mercedes-Benz and Stellantis. Factorial says the funding will be used to accelerate commercial production and deployment of its solid-state battery technology, which the company says is safer, and offers up to 50% more driving range than current lithium-ion technology. Factorial also has joint development agreements (announced in late 2021) with Mercedes-Benz, Stellantis, and Hyundai, three of the top 10 global automotive manufacturers, to commercialize its batteries. Factorial CEO Siyu Huang joined Cheddar News' Closing Bell to discuss.
Load More